Provided By GlobeNewswire
Last update: Aug 8, 2025
FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemistry, Manufacturing, and Controls plans for the product through commercialization.
Read more at globenewswire.comNASDAQ:NTRB (8/29/2025, 8:00:02 PM)
6.465
-0.07 (-1%)
NASDAQ:NTRBW (8/29/2025, 4:47:58 PM)
1.4
-0.1 (-6.67%)
Find more stocks in the Stock Screener